AI adoption in pharma can be slow, but failing to scale these new tools across your organization is a missed opportunity.

There could be an upside to incorporating AI for the FDA. Using AI to assist in final drug reviews would "represent a chance ...

Experts have cautioned against adopting the technology too quickly for clinical purposes. The first meeting of FDA’s Digital ...

Stuart J. Schnitt, MD, discussed how AI enhances cancer diagnoses and the need for professional oversight, ethical clarity, ...

AI-powered tools are enhancing precision, efficiency, and decision-making in biopharmaceutical development. Recently, Jared ...

Donald Trump has promised to create a pro-AI environment, but even tech companies are frustrated by federal cuts that hamper regulatory processes. Paul Webster reports.

Discover how AI is transforming healthcare with insights from Microsoft leaders on AI advancements, success stories, and ...

From real-time triage tools and diagnostic imaging to predictive analytics and drug discovery, AI isn’t just being tested in hospitals ... hospitals are more eager than ever to adopt time-saving, cost ...

Looking Ahead The FDA’s full-scale adoption of AI technology represents a leap forward in regulatory oversight. By ...

As pharmaceutical companies adopt AI technologies, it is essential to explore the opportunities and challenges they present in the quest for innovative healthcare solutions. Traditional drug ...